768 related articles for article (PubMed ID: 19386450)
1. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
Uyar Y; Baytur Y; Inceboz U; Demir BC; Gumuser G; Ozbilgin K
Maturitas; 2009 Jul; 63(3):261-7. PubMed ID: 19386450
[TBL] [Abstract][Full Text] [Related]
2. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
3. The effect of clomiphene citrate on osteoporosis in ovariectomized rats.
Uyar Y; Koltan SO; Pögün S; Vatansever S; Caglar H
Arch Gynecol Obstet; 2008 Aug; 278(2):107-14. PubMed ID: 18193254
[TBL] [Abstract][Full Text] [Related]
4. Dual-energy x-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized rats.
Sato M; McClintock C; Kim J; Turner CH; Bryant HU; Magee D; Slemenda CW
J Bone Miner Res; 1994 May; 9(5):715-24. PubMed ID: 8053401
[TBL] [Abstract][Full Text] [Related]
5. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
[TBL] [Abstract][Full Text] [Related]
6. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
[TBL] [Abstract][Full Text] [Related]
7. [One year observation on effects of estrogen, tamoxifen combined with or without fluoride on preventing bone loss in ovariectomized rats].
Liu H; Peng H; Liu J
Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):82-5. PubMed ID: 11953070
[TBL] [Abstract][Full Text] [Related]
8. Prevention of bone loss in ovariectomized rats by combined treatment with risedronate and 1alpha,25-dihydroxyvitamin D3.
Erben RG; Mosekilde L; Thomsen JS; Weber K; Stahr K; Leyshon A; Smith SY; Phipps R
J Bone Miner Res; 2002 Aug; 17(8):1498-511. PubMed ID: 12162504
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling of rat femur revealed suppression of bone formation genes by treatment with alendronate and estrogen but not raloxifene.
Helvering LM; Liu R; Kulkarni NH; Wei T; Chen P; Huang S; Lawrence F; Halladay DL; Miles RR; Ambrose EM; Sato M; Ma YL; Frolik CA; Dow ER; Bryant HU; Onyia JE
Mol Pharmacol; 2005 Nov; 68(5):1225-38. PubMed ID: 16079270
[TBL] [Abstract][Full Text] [Related]
10. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
Iwaniec UT; Samnegård E; Cullen DM; Kimmel DB
Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
[TBL] [Abstract][Full Text] [Related]
11. Flaxseed combined with low-dose estrogen therapy preserves bone tissue in ovariectomized rats.
Sacco SM; Jiang JM; Reza-López S; Ma DW; Thompson LU; Ward WE
Menopause; 2009; 16(3):545-54. PubMed ID: 19182694
[TBL] [Abstract][Full Text] [Related]
12. The effect of orally administered clodronate on bone mineral density and bone geometry in ovariectomized rats.
Osterman T; Laurén L; Kuurtamo P; Hannuniemi R; Isaksson P; Kippo K; Peng Z; Väänänen HK; Sellman R
J Pharmacol Exp Ther; 1998 Jan; 284(1):312-6. PubMed ID: 9435193
[TBL] [Abstract][Full Text] [Related]
13. Sequential treatment of ovariectomized mice with bFGF and risedronate restored trabecular bone microarchitecture and mineralization.
Yao W; Balooch G; Balooch M; Jiang Y; Nalla RK; Kinney J; Wronski TJ; Lane NE
Bone; 2006 Sep; 39(3):460-9. PubMed ID: 16713415
[TBL] [Abstract][Full Text] [Related]
14. Effects of a prostaglandin EP4 agonist, ONO-4819, and risedronate on trabecular microstructure and bone strength in mature ovariectomized rats.
Ito M; Nakayama K; Konaka A; Sakata K; Ikeda K; Maruyama T
Bone; 2006 Sep; 39(3):453-9. PubMed ID: 16581323
[TBL] [Abstract][Full Text] [Related]
15. Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats.
Fuchs RK; Shea M; Durski SL; Winters-Stone KM; Widrick J; Snow CM
Bone; 2007 Aug; 41(2):290-6. PubMed ID: 17544352
[TBL] [Abstract][Full Text] [Related]
16. Effects of different estrogen and progestin regimens on the mechanical properties of rat femur.
Kasra M; Vanin CM; MacLusky NJ; Casper RF; Grynpas MD
J Orthop Res; 1997 Jan; 15(1):118-23. PubMed ID: 9066535
[TBL] [Abstract][Full Text] [Related]
17. Standardized bending and breaking test for the normal and osteoporotic metaphyseal tibias of the rat: effect of estradiol, testosterone, and raloxifene.
Stürmer EK; Seidlová-Wuttke D; Sehmisch S; Rack T; Wille J; Frosch KH; Wuttke W; Stürmer KM
J Bone Miner Res; 2006 Jan; 21(1):89-96. PubMed ID: 16355277
[TBL] [Abstract][Full Text] [Related]
18. Oral bioavailability and bone-sparing effects of estetrol in an osteoporosis model.
Coelingh Bennink HJ; Heegaard AM; Visser M; Holinka CF; Christiansen C
Climacteric; 2008; 11 Suppl 1():2-14. PubMed ID: 18464016
[TBL] [Abstract][Full Text] [Related]
19. Effects of lasofoxifene on bone in surgically postmenopausal cynomolgus monkeys.
Lees C; Shen V; Brommage R
Menopause; 2007; 14(1):97-105. PubMed ID: 17075430
[TBL] [Abstract][Full Text] [Related]
20. Accretion of bone mass and strength with parathyroid hormone prior to the onset of estrogen deficiency can provide temporary beneficial effects in skeletally mature rats.
Shen V; Birchman R; Liang XG; Wu DD; Dempster DW; Lindsay R
J Bone Miner Res; 1998 May; 13(5):883-90. PubMed ID: 9610753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]